Ruijin Hospital: Lymphoma, Non-Hodgkin trials

The registry lists 12 Lymphoma, Non-Hodgkin studies with Ruijin Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 1Phase 3 1Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After ChemotherapyRecruitingNCT07628738Phase 2
• A Real-World Study on Extranodal LymphomaNot yet recruitingNCT06573099
• Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data CollectionRecruitingNCT06541327
• A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell LymphomaRecruitingNCT06494371Phase 1
• Tumor Microenvironment Mechanism of LY007 for r/r B-NHL and the Exploration of Novel CAR-T Translational ResearchNot yet recruitingNCT06049381
• (CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)Not yet recruitingNCT05923502
• A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin LymphomaRecruitingNCT05852028
• Efficacy and Safety of Lenalidomide With or Without Rituximab and Other Drugs in B-cell Non-Hodgkin's LymphomasStatus unknownNCT04435743
• A Single-cell Transcriptome Study in Patients With Non-Hodgkin's LymphomaStatus unknownNCT04434833
• Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in LymphomaStatus unknownNCT04083079Phase 4
• A Metagenome-wide Association Study of Gut Microbiota in Gastrointestinal Non-Hodgkin's Lymphoma PatientsStatus unknownNCT03930043
• R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3BStatus unknownNCT01852435Phase 3